A new Stanford Medicine-led study found that with a gradual, personalized approach, about half of chronic pain patients significantly cut their opioid use over one year.
Cellular and molecular interactions around tumors give insight into their structures and weaknesses, but measuring them has been expensive and slow. A Stanford Medicine AI platform flips the script.
Antibody therapies show limited success in solid tumors. A new imaging technique developed at Stanford Medicine that locates antibodies at subcellular resolution in human tumors hints at why.
GLP-1s 101: What the science says about weight loss, side effects, safety
We asked Stanford Medicine experts to break down everything you need to know about the drugs known as GLP-1s, semaglutide, Ozempic, Wegovy, Zepbound and many more.
Stanford Medicine’s Leanne Williams was chosen to lead the Precision Mental Health Commission to redefine and streamline how psychiatric conditions are diagnosed and treated. She’s pushing for a data-driven approach that begins with brain imaging.
The emergence of a nasty new virus or even an unexpected flu strain can pose a big public-health headache. Meanwhile, antiviral drug development moves at an agonizingly slow pace and cringingly high cost. But there’s a way around that.
How pregnant women and others can reduce their chemical exposure
Stanford environmental health scientist Tracey Woodruff discusses new research showing widespread exposure among pregnant women to common but understudied chemicals. She highlights what consumers and policymakers can do to protect public health.
A postdoctoral scholar made a 40 under 40 list, a biochemistry professor earned an achievement award and two professors received research grants: one for melanoma immunotherapy and the other to deepen understanding of protein function.
The goal is to develop a vaccine platform that could offer a broad-based defense against a host of respiratory threats: bacteria, viruses, even allergens.
Five Stanford Medicine professors were honored for their work in psychiatry, oncology and diabetes; four were awarded funding for Parkinson’s research; and one was named an emerging leader scholar.
Stanford Medicine is harnessing artificial intelligence to expedite research, advance treatments, improve patient care and achieve better health equity. Follow the latest developments in the integration of AI technologies into biomedicine.
Researchers and physicians at Stanford Medicine are expanding our understanding of how cancer originates and spreads, discovering more effective treatments, and helping prevent recurrence.
The latest news from Stanford Medicine's research and clinical communities as they uncover the secrets of conditions such as epilepsy, autism, stroke, Parkinson’s and Alzheimer’s disease and pioneer treatments for these conditions.
Researchers and physicians at Stanford Medicine are learning the origins of mental illness and finding more effective ways to treat conditions such as depression, anxiety, PTSD and bipolar disorder.
Stanford Medicine researchers are uncovering the secrets of heart conditions such as tachycardia, atrial fibrillation and heart failure while surgeons are advancing techniques for bypass operations, transplantation and fixing congenital heart deformities.
Zboralske was a leading gastrointestinal radiologist and former director of diagnostic radiology at Stanford who is remembered for his infectious enthusiasm and dedication to teaching.
Castellino, who founded the first radiation oncology division at Stanford Medicine, led the diagnostic radiology department and made important contributions to research in imaging the lymphatic system.
Have a media request? Our Office of Communications is ready to assist with press materials and interview opportunities. Let us know how we can help you.
If you are a reporter and would like to be added to our distribution list to receive press releases about Stanford Medicine's research, clinical breakthroughs and organizational updates, please fill out our request form.
